Qui tam troll attacks Allergan

After paying $600 million to settle off-label marketing claims, Allergan agreed to drop its First Amendment challenges to the FDA’s off-label promotion rules.  Now Allergan

READ MORE

On The Record

GAO: Medicare Part D Formularies: CMS Conducts Oversight of Mid-Year Changes… GAO: Private Health Insurance: State Oversight of Premium Rates, GAO-11-701 US 3rd Circuit COA:

READ MORE

Memo to the Super Committee

To: Super Committee Re: Medicare Savings   I know you haven’t been established yet. Neither you, nor I, know who you really are. Still, it’s

READ MORE

The cost of chronic illness

One route to improving health outcomes and potentially reducing health care spending is to focus on individuals with chronic conditions. It’s possible that reducing cost

READ MORE

On The Record

PCORI: call for ideas for Tier 1 Pilot project ideas House of Rep: text of Budget Control Act of 2011 CBO: analysis of Budget Control

READ MORE
Subscribe

Email Address*